WHO Prequalifies Arthritis Drug Tocilizumab for Severe Covid Cases
2022-02-12
Tocilizumab has previously been authorised mostly for the treatment of arthritis in about 120 countries. (Representational Image)Prior to tocilizumab, the WHO has prequalified three different compositions for the steroid dexamethasone for treating Covid, as well as Gilead’s antiviral remdesivir, although that prequalification has since been suspended.AFP Last Updated:February 12, 2022, 09:31 ISTFOLLOW US ON:The World…Continue Reading